Hemogenyx Pharmaceuticals
LSE:HEMOLSE
3 announcements
Credibility Score63%
Hemogenyx Pharmaceuticals — First Patient Treated in Second Adult Dose Cohort
Overhypedunclear
Hemogenyx has begun treating the second cohort in its Phase I CAR-T trial at double dose.
12 Nov 2026, 07:00 UTC
▼
Hemogenyx Pharmaceuticals — Collaboration with Cellin Technologies
OverhypedModerate hypeunclear
Hemogenyx signs its first binding CAR-T therapy deal, but revenue remains months away.
11 Aug 2026, 06:05 UTC
▼
Collaboration and Company Update
OverhypedModerate hypeunclear
Hemogenyx signs a Lithuanian LOI, but all clinical and financial milestones remain unproven.
29 Jul 2026, 06:20 UTC
▼